A. Azuma (Tokyo, Japan), A. Tzouvelekis (Thrace, Greece), A. Prasse (Freiburg, Germany)
LATE-BREAKING ABSTRACT: Coagulation factor IX deficiency does not afford protection from pulmonary fibrosis in the experimental murine bleomycin model
K. Borensztajn, L. Cong, B. Crestani, O. Christophe, A. Spek (Paris, Le Kremlin-Bicêtre, France; Amsterdam, Netherlands)
|  |
LATE-BREAKING ABSTRACT: Aggravation of bleomycin-induced pulmonary fibrosis in senescence-accelerated mouse
B. Lou, Q. Ye, H. Dai, K. Huang, C. Wang (Beijing, China)
| |
Lung function progression in Langerhans cell histiocytosis
S. Krivinskas, P. Ind, A. Chu (London, United Kingdom)
|  |
Correlation between spirometry, six minute walk test and HRCT characteristics of patients with interstitial lung diseases in a tertiary care center in Sri Lanka
A. Siribaddana, M.T. Muthunayake, D.L.B. Dassanayake, N. Nadesan, S. Ileperuma, L. Gamage (Kandy, Sri Lanka)
| |
Uncommonly common? Common variable immunoglobulin deficiency ‘masquerading‘ as sarcoidosis
R. Alluri, D. Miller, A. M. Shanks, R. Herriot, O. Dempsey (Aberdeen, United Kingdom)
| |
Electrocardiographic characteristics in patients with sarcoidosis
E. Gialafos, V. Kouranos, A. Jurado Roman, M. Gallego, J. Jimenez, A. Kallianos, O. Anagnostopoulou, J. Arapis, A. Rapti, G. Tzelepis (Athens, Greece; London, United Kingdom)
| |
Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven
M. Salinas, M. Florenzano, G. Cavada, A. Undurraga (Santiago, Chile)
| |
Pathological findings in histiocytosis X with pulmonary hypertension
J. Villuela, J. Cifrian, B. Abascal, A. Daly, C. Amado, S. Fernandez-Rozas, D. Iturbe, F. Zurbano, R. Mons, J. Gomez-Román (Santander, Spain)
| |
A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening
G. Paone, G. L. Di Tanna, S. Batzella, F. Belli, S. D‘Antonio, M. G. Alma, G. Schmid, G. Puglisi, A. Vestri (Rome, Italy)
| |
Characteristic of gender distribution in sarcoidosis
J. Videnovic-Ivanov, V. Vucinic, S. Filipovic, V. Zugic, J. STojsic (Belgrade, Republic Of Montenegro)
| |
Is T-SPOT.TB performance in bronchoalveolar lavage usuful in differential diagnosis between sarcoidosis and tuberculosis? – Pilot study
A. Kempisty, P. Radwan-Rohrenschef, D. Borkowska, E. Augustynowicz-Kopec, J. Kus (Warsaw, Poland)
| |
Sarcoidosis in Sao Paulo, Brazil: Clinical, tomographic and lung functions data from 72 patients
A. H. Medeiros-Neto, F. G. Rodrigues, C. R. R. Carvalho, R. A. Kairalla (Sao Paulo, Brazil)
| |
Coexistance of idiopathic pulmonary hemosiderosis and celiac disease: Complete remission with gluten free diet
M. Aydogan, A. Gundogan, E. Ucar, C. Tasci, S. Gumus, Z. Polat, O. Deniz, E. Tozkoparan, M. Ozkan, H. Bilgic (Ankara, Turkey)
| |
M2 chemokines during acute exacerbations of IPF
J. Schupp, C. Kollert, B. Jäger, J. Müller-Quernheim, A. Prasse (Freiburg, Germany)
| |
Effects of aerobic and strength training on symptoms and exercise capacity of IPF patients
R. Jackson, C. Ramos, D. Cardenas, C. Sol, M. Cohen, I. Gaunaurd, N. Eustis, O. Gomez-Marin (Miami, United States Of America)
| |